Unlearn Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 74

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 13

Unlearn General Information

Description

Developer of machine-learning models designed to create digital twins used to populate intelligent control arms in clinical studies. The company's technology accelerates clinical trials by supplementing control groups with synthetic patient data generated using AI, which helps reduce the time to develop new medicines, enabling healthcare companies to provide patients in need with life-saving therapies.

Contact Information

Website
www.unlearn.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 303 2nd Street
  • Suite N460
  • San Francisco, CA 94107
  • United States
+1 (415)
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 303 2nd Street
  • Suite N460
  • San Francisco, CA 94107
  • United States
+1 (415)

Unlearn Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Unlearn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Generating Revenue
5. Later Stage VC (Series C) 25-Jan-2024 Completed Generating Revenue
4. Later Stage VC (Series B1) 21-Mar-2023 Completed Generating Revenue
3. Later Stage VC (Series B) 16-Aug-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Nov-2020 $15M $19.9M Completed Generating Revenue
1. Seed Round 01-Mar-2019 $4.85M $4.85M Completed Startup
To view Unlearn’s complete valuation and funding history, request access »

Unlearn Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B-1
Series B
Series A 7,108,331 $0.000100 $2.11 $2.11 1x $2.11 18.25%
Seed 4,074,875 $0.000100 $1.27 $1.27 1x $1.27 10.46%
To view Unlearn’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Unlearn Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of machine-learning models designed to create digital twins used to populate intelligent control arms in clini
Discovery Tools (Healthcare)
San Francisco, CA
74 As of 2026

Gaithersburg, MD
 

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Unlearn Competitors (5)

One of Unlearn’s 5 competitors is BullFrog AI, a Formerly VC-backed company based in Gaithersburg, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BullFrog AI Formerly VC-backed Gaithersburg, MD
AiCure Venture Capital-Backed Houston, TX
Trials.ai Venture Capital-Backed Princeton, NJ
Deep 6 AI Formerly VC-backed Pasadena, CA
ConcertAI Private Equity-Backed Cambridge, MA
You’re viewing 5 of 5 competitors. Get the full list »

Unlearn Patents

Unlearn Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250384974-A1 Systems and methods for optimizing composite scores Pending 18-Jun-2024
US-20250259717-A1 Systems and methods for optimizing clinical trial designs Pending 13-Feb-2024
US-20250131332-A1 Systems and methods for bayesian prognostic covariate adjustment Pending 18-Oct-2023
US-20250078965-A1 Systems and methods for adjusting covariates and producing treatment effect inferences in randomized controlled trials Inactive 28-Aug-2023
US-11868900-B1 Systems and methods for training predictive models that ignore missing features Active 22-Feb-2023 G06N3/096
To view Unlearn’s complete patent history, request access »

Unlearn Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Unlearn Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altimeter Capital Management Venture Capital Minority
Eisai Corporate Venture Capital Minority
Parkway Venture Capital Venture Capital Minority
Insight Partners (New York) PE/Buyout Minority
Necessary Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Unlearn FAQs

  • When was Unlearn founded?

    Unlearn was founded in 2017.

  • Where is Unlearn headquartered?

    Unlearn is headquartered in San Francisco, CA.

  • What is the size of Unlearn?

    Unlearn has 74 total employees.

  • What industry is Unlearn in?

    Unlearn’s primary industry is Discovery Tools (Healthcare).

  • Is Unlearn a private or public company?

    Unlearn is a Private company.

  • What is Unlearn’s current revenue?

    The current revenue for Unlearn is .

  • How much funding has Unlearn raised over time?

    Unlearn has raised $135M.

  • Who are Unlearn’s investors?

    Altimeter Capital Management, Eisai, Parkway Venture Capital, Insight Partners (New York), and Necessary Ventures are 5 of 13 investors who have invested in Unlearn.

  • Who are Unlearn’s competitors?

    BullFrog AI, AiCure, Trials.ai, Deep 6 AI, and ConcertAI are competitors of Unlearn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process